1. Home
  2. ALT vs FET Comparison

ALT vs FET Comparison

Compare ALT & FET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALT
  • FET
  • Stock Information
  • Founded
  • ALT 1997
  • FET 2005
  • Country
  • ALT United States
  • FET United States
  • Employees
  • ALT N/A
  • FET N/A
  • Industry
  • ALT Biotechnology: Pharmaceutical Preparations
  • FET Metal Fabrications
  • Sector
  • ALT Health Care
  • FET Industrials
  • Exchange
  • ALT Nasdaq
  • FET Nasdaq
  • Market Cap
  • ALT 333.6M
  • FET 309.5M
  • IPO Year
  • ALT N/A
  • FET 2012
  • Fundamental
  • Price
  • ALT $3.93
  • FET $26.47
  • Analyst Decision
  • ALT Strong Buy
  • FET
  • Analyst Count
  • ALT 6
  • FET 0
  • Target Price
  • ALT $17.40
  • FET N/A
  • AVG Volume (30 Days)
  • ALT 3.0M
  • FET 113.8K
  • Earning Date
  • ALT 11-11-2025
  • FET 10-30-2025
  • Dividend Yield
  • ALT N/A
  • FET N/A
  • EPS Growth
  • ALT N/A
  • FET N/A
  • EPS
  • ALT N/A
  • FET N/A
  • Revenue
  • ALT $20,000.00
  • FET $801,867,000.00
  • Revenue This Year
  • ALT N/A
  • FET N/A
  • Revenue Next Year
  • ALT N/A
  • FET $0.80
  • P/E Ratio
  • ALT N/A
  • FET N/A
  • Revenue Growth
  • ALT N/A
  • FET 3.86
  • 52 Week Low
  • ALT $2.90
  • FET $12.78
  • 52 Week High
  • ALT $11.16
  • FET $28.78
  • Technical
  • Relative Strength Index (RSI)
  • ALT 52.80
  • FET 47.19
  • Support Level
  • ALT $3.85
  • FET $25.25
  • Resistance Level
  • ALT $4.06
  • FET $26.31
  • Average True Range (ATR)
  • ALT 0.20
  • FET 0.89
  • MACD
  • ALT 0.02
  • FET -0.37
  • Stochastic Oscillator
  • ALT 57.35
  • FET 16.76

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

About FET Forum Energy Technologies Inc.

Forum Energy Technologies Inc is a products company, serving the oil, natural gas, industrial and renewable energy industries. The company designs, manufactures, and distributes products and engages in aftermarket parts supply and services that complement its product offering. Its products include engineered capital equipment, as well as products that are consumed in the drilling, well construction, production, and transportation of oil and natural gas. It operates in two reporting segments, namely Drilling and Completions and Artificial Lift and Downhole. Revenue largely comes from Artificial Lift and Downhole segment.

Share on Social Networks: